OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
The massive trading volume that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has attracted over the past few months has taken even greater heights on Monday as the biotechnology company focused on the development of regenerative medicine therapies and tools to … Continue reading →
Few companies in the penny stock market have attracted the kind of attention that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has over the past week and on Friday that attention hit a new level with more than 121 million shares … Continue reading →
It would be safe to say that several investors have lost a considerable amount of sleep, as well as money, in their dealings with Dendreon Corp. (NASDAQ: DNDN) as the biotechnology company has hit highs near the $60 level while … Continue reading →
For a company that hasn’t issued a press release since April 30, 2012 there has been a tremendous amount of interest in Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) as the biotechnology company has seen massive trading volume and Friday has … Continue reading →
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading →
Posted in AMEX, Articles
|
Tagged biotechnology, cancer, cmv, hiv, hpv, ino, inovio pharmaceuticals, investors, medical issues, virus
|
Amarantus BioSciences, Inc. (OTCBB: AMBS) is positioning itself to close the week on a high note as the biotechnology company that develops new treatments and diagnostics for Parkinson’s disease and Traumatic Brain Injury centered on their proprietary anti-apoptotis therapeutic protein … Continue reading →
While shares of Northwest Biotherapeutics (OTCQB: NWBO) haven’t quite reached the same levels they were at a year ago it appears as if investors are encouraged by the recent advancements the biotechnology company has made and trading activity has reflected … Continue reading →
One year ago shares of Dendreon Corp. (NASDAQ: DNDN) were trading at a 52-week high of 37.19 and the darling of the biotechnology industry with a prostate cancer drug on the market that was almost certainly going to bring in … Continue reading →
While BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) announced on Tuesday their intention to sell 19.8 million shares of their common stock at 29 cents each, effectively raising an estimated $4.78 million, investors found little reason to ignite a buying frenzy … Continue reading →
Posted in Uncategorized
|
Tagged als, bcli, biotechnology, brainstorm cell, fda, investors, ms, nurown, pd, stem cell, stem cells
|
After a slow start to the month in which they hit a low of 2.05 shares of ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) have been on strong run as the biotechnology company focused on the development of novel immune-based cancer therapies … Continue reading →
